Pediatric Artificial Intelligence for Retinopathy Screening in Children With Type 1 Diabetes
- NCT ID
- NCT07149142
- Registry status
- Recruiting
- Study type
- Not specified in the registry data
- Phase
- Not applicable
- Sponsor
- University Hospital, Motol
Overview
ClinicalTrials.gov lists this study as Recruiting.
Enrollment: 400 participants (Estimated).
What is being studied
No interventions are listed in the registry data.
Who may be eligible
- Ages
- Not specified in the registry data
- Sex
- Not specified in the registry data
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Inclusion Criteria:
* Type 1 diabetes diagnosed according to the ADA criteria
* Age over 11.0 years or duration of diabetes over 2 years
* Signed written informed consent by both the CwD and their parent/caregiver
Exclusion Criteria:
* Unwillingness to sign a written informed consent by both the CwD and their parent/caregiver
Study locations
1 study location is listed.
Site recruitment status is not specified in the registry data for these locations.
Countries: Czechia
- Prague 5, Czechia: 1
Sample of listed locations
- University Hospital Motol — Prague, Prague 5, 15006, Czechia — Site recruitment status not specified in the registry data
Study details
- Start date
- July 1, 2026
- Primary completion date
- December 31, 2027
- First posted
- August 29, 2025
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07149142
- Registry last updated
- July 20, 2026
- QualifiedStudies registry data refreshed
- September 21, 2026
View NCT07149142 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Diabetic Neuropathy studies | Clinical trial FAQ